Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Dunelm, Gear4Music, Morrisons and more news from the past week

AJ Bell is an easy to use, award-winning platform Open an account
We've accounts to suit every investing need, and free guides and special offers to help you get the most from them.
You can get a few handy suggestions, or even get our experts to do the hard work for you – by picking one of our simple investment ideas.
All the resources you need to choose your shares, from market data to the latest investment news and analysis.
Funds offer an easier way to build your portfolio – we’ve got everything you need to choose the right one.
Starting to save for a pension, approaching retirement, or after an explainer on pension jargon? We can help.
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
The amount of corporate news has been fairly limited since the Christmas break as investors await festive trading updates with some trepidation. So far Next (NXT) and Dunelm (DNLM) have been particularly well received by investors and Gear4Music (G4M:AIM) has been the biggest shocker.
Homewares retailer Dunelm saw its shares soar on 7 January after reporting 9% growth in second quarter revenue growth. Its like-for-like store revenue rose 5.7% to £246.4m, while comparable online sales shot up by a forecast-busting 38% to £36.1m. The company also announced plans to launch a new, more flexible web platform to build on the strong contribution from internet-based sales.
Online musical instruments firm Gear4Music was heavily out of favour on 4 January with its shares at one stage losing more than 50% of their value after a major profit warning.
In some respects Gear4Music is a victim of its own success. Sales growth of 41% in the final four months of 2018 was impressive. Yet it hit capacity constraints and will now have to invest to get up to speed. Earnings for the year to 28 February 2019 will subsequently come in below the previous year’s result.
Pharmaceutical business Vectura (VEC) got the thumbs-up from the market with its full year trading update (3 Jan). Despite revenue guidance being left unchanged the company said earnings would be ‘materially ahead’ of expectations.
Improvements in margin performance, progress on productivity and a better mix of business all contributed to the beat.
In the groceries space Morrisons (MRW) was first in its sector with a Christmas update on 8 January and ultimately disappointed the market.
Chief executive David Potts faced a tough task after a bumper festive period the previous time round and like-for-like retail growth of just 0.6% seemed to be the main sticking point for investors. This figure was down from the 1.3% reported in the third quarter and 2.1% growth from a year earlier.
These articles are provided by Shares magazine which is published by AJ Bell Media, a part of AJ Bell. Shares is not written by AJ Bell.
Shares is provided for your general information and use and is not a personal recommendation to invest. It is not intended to be relied upon by you in making or not making any investment decisions. The investments referred to in these articles will not be suitable for all investors. If in doubt please seek appropriate independent financial advice.
Investors acting on the information in these articles do so at their own risk and AJ Bell Media and its staff do not accept liability for losses suffered by investors as a result of their investment decisions.
The value of your investments can go down as well as up and you may get back less than you originally invested. We don't offer advice, so it's important you understand the risks, if you're unsure please consult a suitably qualified financial adviser. Tax treatment depends on your individual circumstances and rules may change. Past performance is not a guide to future performance and some investments need to be held for the long term.